GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $33.24 $45.00 Thursday, 18th Apr 2024 CRBP stock ended at $36.53. This is 1.70% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.15% from a day low at $35.26 to a day high of $37.78.
90 days $6.63 $49.87
52 weeks $3.03 $49.87

Historical Corbus Pharmaceuticals Holdings prices

Date Open High Low Close Volume
2024-02-06 $25.04 $27.09 $25.03 $26.00 391 452
2024-02-05 $25.60 $26.55 $24.13 $26.16 298 164
2024-02-02 $26.36 $28.67 $25.90 $26.72 515 855
2024-02-01 $25.90 $28.00 $24.06 $27.79 776 434
2024-01-31 $28.45 $29.30 $23.55 $26.49 4 726 829
2024-01-30 $21.01 $26.27 $19.34 $25.16 1 807 652
2024-01-29 $24.90 $26.90 $17.66 $18.62 3 399 805
2024-01-26 $16.81 $39.96 $16.25 $29.49 32 939 106
2024-01-25 $7.80 $8.47 $7.49 $8.44 119 532
2024-01-24 $7.44 $8.20 $7.44 $7.53 13 690
2024-01-23 $7.99 $8.01 $7.30 $7.30 86 623
2024-01-22 $6.97 $8.45 $6.63 $7.60 103 024
2024-01-19 $7.09 $7.17 $6.66 $7.05 19 006
2024-01-18 $6.20 $7.30 $6.20 $6.92 113 128
2024-01-17 $5.97 $6.39 $5.87 $6.15 11 161
2024-01-16 $5.90 $6.36 $5.85 $6.09 32 303
2024-01-12 $6.24 $6.33 $5.71 $5.93 17 914
2024-01-11 $6.45 $6.45 $6.15 $6.24 10 724
2024-01-10 $7.19 $7.19 $6.30 $6.42 23 464
2024-01-09 $7.40 $7.40 $7.10 $7.22 33 945
2024-01-08 $6.39 $7.40 $6.22 $7.16 83 831
2024-01-05 $6.25 $6.27 $6.09 $6.12 6 368
2024-01-04 $6.13 $6.41 $6.13 $6.39 8 343
2024-01-03 $6.08 $6.31 $6.03 $6.13 11 183
2024-01-02 $6.01 $6.36 $6.01 $6.33 12 384
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT